153Sm-DOTMP (153Sm-CycloSAM) is a bone pain palliation agent under development by the US company Isotherapeutics. Original patents are dated from 1989. This product must be considered as a generic, was considered as on hold and is now (2020) reactivated and developed by the company QSAM Biosciences, Inc. It localizes to bone surfaces in the same way as 153Sm-EDTMP (Quadramet®)
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.